Source:http://linkedlifedata.com/resource/pubmed/id/12013554
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-5-15
|
pubmed:abstractText |
The purpose of this study was to investigate the expression of human beta-defensins (hBD), especially of the recently discovered hBD-3, in oral tissues by reverse-transcription polymerase chain reaction (RT-PCR). Primary oral keratinocytes (n = 3) and fibroblasts (n = 3), 64 non-inflamed and 40 inflamed oral tissue samples, and 10 samples of salivary glands, were examined. The transcripts for hBD-3 (61/64), as well as for hBD-1 (64/64) and hBD-2 (54/64), were found to be widely expressed in non-inflamed oral tissues. In contrast, only 23, 22 and 24 of the 40 inflamed tissues showed detectable hBD-1, -2 and -3 transcripts, respectively. In salivary glands, mRNA expression was constitutive for hBD-1, frequent for hBD-2 (9/10), and infrequent for hBD-3 (4/10). Oral keratinocytes, but not fibroblasts, contained transcripts for all beta-defensins, suggesting that the novel hBD-3 is also produced in the epithelial compartment of oral tissues. The results indicate an important role for the novel hBD-3, as well as for hBD-1 and hBD-2, in the innate oral epithelial host defense.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
D
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DEFB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DEFB4A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Defensins,
http://linkedlifedata.com/resource/pubmed/chemical/beta-defensin 3, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0909-8836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-4
|
pubmed:dateRevised |
2010-9-17
|
pubmed:meshHeading |
pubmed-meshheading:12013554-Anti-Bacterial Agents,
pubmed-meshheading:12013554-Cells, Cultured,
pubmed-meshheading:12013554-Chi-Square Distribution,
pubmed-meshheading:12013554-Gingiva,
pubmed-meshheading:12013554-Gingivitis,
pubmed-meshheading:12013554-Humans,
pubmed-meshheading:12013554-Immunity, Mucosal,
pubmed-meshheading:12013554-Keratinocytes,
pubmed-meshheading:12013554-Mouth Mucosa,
pubmed-meshheading:12013554-Periodontitis,
pubmed-meshheading:12013554-RNA, Messenger,
pubmed-meshheading:12013554-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12013554-Salivary Glands,
pubmed-meshheading:12013554-beta-Defensins
|
pubmed:year |
2002
|
pubmed:articleTitle |
The novel human beta-defensin-3 is widely expressed in oral tissues.
|
pubmed:affiliation |
Department of Oral and Maxillofacial Surgery, University Hospital Kiel, Germany. dunsche@mkg.uni-kiel.de
|
pubmed:publicationType |
Journal Article
|